1.Clinical features and inununophenotypes of 23 cases mantle cell lymphoma
Qiao-hong NIU ; Xi LI ; Zong NG ZHA
Journal of Leukemia & Lymphoma 2011;20(10):606-607
ObjectiveTo investigation the clinical features and immunophenotypes of mantle cell lymphoma (MCL).MethodsThe clinical data of 23 patients of MCL were reviewed prospectively.Age,sex,Ann-Arbor staging,symptoms and bone marrow biopsies were analyzed.Serum lactat dehydrogenates (LDH) level,CD5,CD20 and CyclinD1 were determined.ResultsThe median age was 62 years old (range 44-74),15 patients(65.2%)were more than 60 years old.Among 23 patients,the male-to-female ratio was 4.4∶1,Twenty-one patients (91%) presented with advanced stage (Ann Arbor stage Ⅲ 12 cases and Ⅳ 9 cases) at initial diagnosis.Twenty patients (87.0 %) were lymph node involvement.The serum LDH level was high in 11 patients.CD5 was positively expressed in 14 (60.8 %) of all patients.CD20 was positively expressed in 21 (91.3 %) of all patients.Cyclin D1 was over-expression in 19 (82.6 %) of all patients.ConclusionThe MCL shows a predilection for occurrence in older males.The majority of patients are advanced stage disease (Ann Arbor stage Ⅲ/Ⅳ ) are at initial diagnosis. Most of patients display lymph node involvement manifestations.Bone marrow infiltration is frequent.The immunophenotype of MCL resembles the mature B-lymphocyte (CD+20),with coexprssion of the T-cell antigen CD5.It has been demonstrated that CyclinD1 are over express in this histotype of MCL.CyclinDl over-expression could be considered as hallmark of MCL.
2.Influence of recombinant thioredoxin on apoptosis of myocardium cell in viral myocarditis of mice
Ning, LI ; Min, KANG ; Zong-yan, TENG ; Yi-na NG ZHA ; Hai-jin NG ZHA ; Ying-jun, LI ; Ling-wang, ZHOU
Chinese Journal of Endemiology 2012;31(2):172-176
ObjectiveTo investigate the influence of recombinant thioredoxin (TRX)on apoptosis of myocardium cell in viral myocarditis of mice.MethodsTwenty-four Balb/c mice,weighting 12 - 14 g,were randomly divided into 3 groups:the control group,the virus group and the protective group,8 mice in each group.The virus group and the protective group were injected with 0.1 ml 100TCID50 Coxackie virus B3 (CVB3)intraperitoneally,and the control group was injected equal volume of saline.Therewithal the protective group was injected with TRX(2 mg/kg) by tail vein,and the virus group was injected saline the same way.After 14 days all mice were killed and hearts were taken.Changes of myocardial histopathology was observed with optical microscope,cell apoptosis was checked by TUNEL technique,and the expression of apoptosis-related proteins (Bcl-2,caspase-3)in infiltrated cell of myocardium was determined by immunohistochemistry.Results(①)Lymphocyte infiltration and necrosis were observed in survivals of the virus group,sporadic coagulation necrosis and ballooning degeneration of cells were observed in the protective group,however no myocardial lesion was found in the control group.(②)TUNEL technique showed that the positive ratio of apoptosis in the virus group and the protective group[(90.23 ± 3.63)%,(20.02 ± 2.41)%] was significantly higher than that of the control group(0.00 ± 0.00,all P < 0.05),the positive ratio of apoptosis in the protective group was significantly lower than that of the virus group (P < 0.05 ).(③)Immunohistochemistry showed that the expression of protein Bcl-2(+,++,+++) in the virus group and the protective group was significantly higher than that of the control group (all P < 0.05).The expression of protein Bcl-2 in the protective group was significantly higher than that of the virus group(P < 0.05).The expression of caspase-3 (+,++) was significantly higher in the virus group and the protective group than the control group (all P < 0.05).Compared with the virus group,the expression of caspase-3 in the protective group was significantly lower(P < 0.05).ConclusionTRX could inhibit cardiomyocyte apoptosis in viral myocarditis mice and the inhibition is related to regulation of apoptosis-related protein expression.
3.An analysis of 166 patients with hyperprolactinemia
She-Peng WEI ; Ji-Zong ZHAO ; Fan-Min ZHOU ; Kan DING ; Wei-feng NG ZHA ; Zhi-Yang SUN ; Yanfei ZHANG ; Liang WEI ; Cheng YANG ; Kui-Ming ZHANG
Chinese Journal of Neuromedicine 2011;10(9):934-937
Objective To study the clinical manifestations and treatment methods of hyperprolactinemia (HPRL), a common disorder encountered in clinical practice, and explore its association with prolactinomas. Methods The clinical data, hormone profile and imaging data of 166females with documented HPRL, admitted to our hospital from January 2005 to January 2010, for over a period of 5 years, including 4 years of retrospective analysis and 1 year of prospective study, were retrospectively analyzed. Results Most patients aged 20-40 with abnormal menstruation as their most common symptom; 141 patients (84.9%) appeared abnormal menstruation and 1 14 (68.7%) with galactorrhea. Microadenoma was noted in 62 patients (37.3%), nonfunctioning pituitary macroadenoma involved stalk occurred in 26 patients (15.7%). As compared with that in patients with idiopathic HPRL ([93.9±20.4]ng/mL), the level ofprolactin in patients with microprolactinoma ([161.2±60.6]ng/mL) was significantly higher (P<0.05); as compared with that in patients with prolactin microadenoma, the level of prolactin in patients with domperidone caused drug-induced HPRL ([240.2±29.4]ng/mL) was obviously increased (P<0.05). Conclusion We cannot confirm whether a HPRL patient has prolactinomas only through detecting the level of prolactin. Microprolactinoma is the most common cause of HPRL, followed by idiopathic cause.